By understanding the challenges associated with Investigator Sponsored Trials (IST), stakeholders can utilize ISTs to deliver high-contrast clinical data on underserved patients.

Context Therapeutics, a clinical-stage biopharmaceutical company dedicated to advancing medicines for hormone driven cancers, today announced that chief executive officer Martin Lehr will deliver a corporate presentation at Biotech Showcase™ 2020, being held January 13-15, 2020, at the Hilton San Francisco Union Square in San Francisco.